American Journal of Hematology

Published by: John Wiley & Sons, Inc.  

People

  1. Thompson
    Thompson

Groups

  1. Department of Medicine (5)
  2. Hematologic Malignancies, Division of (5)
  3. Adult Leukemia (4)
  4. Center for Hematologic Malignancies (4)
  5. GME, Medicine (2)
  6. Graduate Medical Education (2)
  7. Hematology-Oncology Fellows (2)
Search Within
  1. "Lindsey Roeker"
Formats
  1. Research Letter (3)
  2. Journal Article (1)
  3. Review (1)
Groups
  1. Department of Medicine (5)
  2. Hematologic Malignancies, Division of (5)
  3. Adult Leukemia (4)
  4. Center for Hematologic Malignancies (4)
  5. GME, Medicine (2)
  6. Graduate Medical Education (2)

More Groups

People
  1. Lindsey Roeker (5)
  2. Anthony Mato (4)
  3. Meghan Thompson (2)
  4. Julia Aronson (1)
Years
  1. 2025 (2)
  2. 2022 (1)
  3. 2020 (1)
  4. 2018 (1)
Publishers
  1. John Wiley & Sons, Inc. (4)
  2. John Wiley & Sons (1)

Results (5)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • BTK inhibitors versus venetoclax as first- or second-line therapy in chronic lymphocytic leukemia/small lymphocytic lymphoma: A real-world evidence study
    Research Letter

    Roeker, L. E.; Han, Y.; Teschemaker, A.; Mato, A. R.; Thompson, M. C.
    American Journal of Hematology (2025)

    Fulltext@MSK | Save
  • Treatment effectiveness of venetoclax-based therapy after Bruton tyrosine kinase inhibitors in chronic lymphocytic leukemia: An International Real-World Study
    Research Letter

    Ghosh, N.; Eyre, T. A.; Brown, J. R.; Lamanna, N.; Manzoor, B. S.; Coombs, C. C.; Tuncer, H. H.; Ujjani, C.; Leslie, L. A.; Roeker, L. E.; more...
    American Journal of Hematology (2025)

    Fulltext@MSK | Save
  • Approach to a patient with “double refractory” chronic lymphocytic leukemia: “Double, double toil and trouble” (Shakespeare)
    Review

    Aronson, J. H.; Skånland, S. S.; Roeker, L. E.; Thompson, M. C.; Mato, A. R.
    American Journal of Hematology (2022)

    Fulltext@MSK | Save
  • Management of CLL patients early in the COVID-19 pandemic: An international survey of CLL experts
    Research Letter

    Koffman, B.; Mato, A.; Byrd, J. C.; Danilov, A.; Hedrick, B.; Ujjani, C.; Roeker, L.; Stephens, D. M.; Davids, M. S.; Pagel, J. M.; more...
    American Journal of Hematology (2020)

    Fulltext@MSK | Save
  • Outcomes of front-line ibrutinib treated CLL patients excluded from landmark clinical trial
    Journal Article

    Mato, A. R.; Roeker, L. E.; Allan, J. N.; Pagel, J. M.; Brander, D. M.; Hill, B. T.; Cheson, B. D.; Furman, R. R.; Lamanna, N.; Tam, C. S.; more...
    American Journal of Hematology (2018)

    Fulltext@MSK | Save

    • American Journal of Hematology – authorized name for:

    Name ISSN / ISBN Publisher
    American Journal of Hematology 0361-8609 John Wiley & Sons, Inc.
    American Journal of Hematology 0361-8609 John Wiley & Sons
    American Journal of Hematology 0361-8609 John Wiley & Sons
    American Journal of Hematology 03618609 Wiley Periodicals LLC
    American Journal of Hematology 03618609 Unknown
    American Journal of Hematology 0361-8609 Wiley Blackwell
    American Journal of Hematology 0361-8609 Unknown
    American Journal of Hematology 0361-8609 Wiley Blackwell
    American Journal of Hematology 03618609 Wiley Liss
    American Journal of Hematology 0361-8609 Wiley Liss, Inc
    American Journal of Hematology 03618609 The Authors American Journal of Hematology Wiley Periodicals, Inc
    American journal of hematology 10968652 Unknown
    American journal of hematology 10968652 Wiley Blackwell
    American Journal of Hematology 10968652 Wiley Blackwell
    American Journal of Hematology 0361-8609 Wiley Periodicals LLC
    American Journal of Hematology 03618609 Wiley‐liss, Inc., A Wiley Company
    American Journal of Hematology 03618609 Wiley Periodicals, Inc